In Vivo Screening Data Summary

NCI In Vivo Screening Data

Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice

NSC 755
CAS 50-44-2
Mercaptopurine; 6-Purinethiol; 6-Mercaptopurine

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q01DX010 (sc) mean tumor weight change Klucel (hydroxypropylcellulose) (HPC) 3.13 mg/kg/injection 133.0 Antitumor endpoint evaluated on day 11; 02/02 animals surviving on day 11
Q01DX010 (sc) mean tumor weight change Klucel (hydroxypropylcellulose) (HPC) 5.25 mg/kg/injection 118.0 Antitumor endpoint evaluated on day 11; 02/02 animals surviving on day 11
Q01DX010 (sc) mean tumor weight change Klucel (hydroxypropylcellulose) (HPC) 12.5 mg/kg/injection 79.0 Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11
Q01DX010 (sc) mean tumor weight change Klucel (hydroxypropylcellulose) (HPC) 12.5 mg/kg/injection 72.0 Antitumor endpoint evaluated on day 11; 02/03 animals surviving on day 11
Q01DX010 (sc) mean tumor weight change Klucel (hydroxypropylcellulose) (HPC) 25.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 11; 01/03 animals surviving on day 11
Q01DX010 (sc) mean tumor weight change Klucel (hydroxypropylcellulose) (HPC) 25.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 11; 00/03 animals surviving on day 11
Q01DX010 (sc) mean tumor weight change Klucel (hydroxypropylcellulose) (HPC) 50.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 11; 00/03 animals surviving on day 11
Q01DX010 (sc) mean tumor weight change Klucel (hydroxypropylcellulose) (HPC) 100.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 11; 00/02 animals surviving on day 11